JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 7, 2006; DOI: 10.1124/jpet.105.100446


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.100446v1
317/2/890    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doherty, M. M.
Right arrow Articles by Pang, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doherty, M. M.
Right arrow Articles by Pang, K. S.


Received for publication December 27, 2005.
Revised February 2, 2006.
Accepted for publication February 2, 2006.

Transport Is Not Rate-Limiting in Morphine Glucuronidation In the Single Pass Perfused Rat Liver Preparation

Margaret M. Doherty 1, Karen Poon 2, Carol Tsang 3, K. Sandy Pang 4*

1 Victoria College of Pharmacy, Monash University, Melbourne, Australia 2 Faculty of Pharmacy, University of Toronto 3 Dept Pharmacology, Faculty of Medicine, University of Toronto 4 Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada

* Address correspondence to: E-mail: ks.pang{at}utoronto.ca

Abstract

Binding, transport and metabolism are factors that influence morphine (M) removal in the rat liver. For M and the morphine 3{beta}-glucuronide metabolite (M3G), modest binding existed with 4% BSA (unbound fractions of 0.89 ± 0.07 and 0.98 ± 0.09, respectively), and there was partitioning of M into red blood cells. Transport studies of M (<750 µM) showed similar, concentration-independent uptake clearances of 1.5 ml.min-1.g-1 among zonal and homogeneous, isolated rat hepatocytes. Transport of M3G, ascertained in multiple indicator dilution (MID) studies at various steady-state M3G concentrations (10-262 µM), uncovered a low and concentration-independent influx clearance (< 10% of flow rate). The outflow dilution curve of [3H]M3G was superimposable onto that of [14C]sucrose, the extracellular reference, displaying similarity in transit times (23.5 s and 22.2 s), negligible biliary excretion, and almost complete dose-recovery from perfusate. In contrast, M3G appeared abundantly in both perfusate and bile in single pass perfusion studies of the precursor, M, and revealed a biliary clearance of formed M3G that was 12.3-fold that of preformed M3G, suggesting a sinusoidal, diffusional barrier for M3G. With increasing concentrations of M (9 to 474 µM), clearance decreased, and metabolism and biliary excretion displayed concentration-dependent kinetics. Fitting of the data to a physiologically-based liver model revealed that M removal mechanisms were saturable, with a Km,met of 52.2 µM and Vmax,met of 58.8 nmole.min-1.g-1 for metabolism, and a Km,ex, of 41.2 µM and Vmax,ex of 8.1 nmole.min-1.g-1 for excretion. Sinusoidal transport was not rate-limiting for M removal.


Key words: glucuronidation, liver model, liver perfusion, morphine, rat hepatocytes, transport


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
A. Rowland, D. J. Elliot, K. M. Knights, P. I. Mackenzie, and J. O. Miners
The "Albumin Effect" and in Vitro-in Vivo Extrapolation: Sequestration of Long-Chain Unsaturated Fatty Acids Enhances Phenytoin Hydroxylation by Human Liver Microsomal and Recombinant Cytochrome P450 2C9
Drug Metab. Dispos., May 1, 2008; 36(5): 870 - 877.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.